Adverum Biotechnologies Inc (ADVM)
8.01
-0.24
(-2.91%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Adverum Biotechnologies Free Cash Flow (Quarterly): -23.34M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -23.34M |
December 31, 2023 | -21.52M |
September 30, 2023 | -24.41M |
June 30, 2023 | -23.28M |
March 31, 2023 | -22.50M |
December 31, 2022 | -18.66M |
September 30, 2022 | -32.63M |
June 30, 2022 | -35.31M |
March 31, 2022 | -33.30M |
December 31, 2021 | -30.17M |
September 30, 2021 | -31.52M |
June 30, 2021 | -37.56M |
March 31, 2021 | -23.71M |
December 31, 2020 | -23.66M |
September 30, 2020 | -29.63M |
June 30, 2020 | -20.02M |
March 31, 2020 | -17.83M |
December 31, 2019 | -23.21M |
September 30, 2019 | -15.72M |
June 30, 2019 | -14.08M |
March 31, 2019 | -15.40M |
December 31, 2018 | -12.89M |
September 30, 2018 | -17.17M |
Date | Value |
---|---|
June 30, 2018 | -11.52M |
March 31, 2018 | -13.20M |
December 31, 2017 | -12.30M |
September 30, 2017 | -10.17M |
June 30, 2017 | -11.89M |
March 31, 2017 | -12.08M |
December 31, 2016 | -9.266M |
September 30, 2016 | -10.01M |
June 30, 2016 | -9.228M |
March 31, 2016 | -12.28M |
December 31, 2015 | -9.314M |
September 30, 2015 | -10.54M |
June 30, 2015 | -10.32M |
March 31, 2015 | -8.153M |
December 31, 2014 | -5.419M |
September 30, 2014 | -5.078M |
June 30, 2014 | 5.30M |
March 31, 2014 | -1.394M |
December 31, 2013 | -0.73M |
September 30, 2013 | -0.591M |
June 30, 2013 | -0.723M |
March 31, 2013 | -0.222M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.56M
Minimum
Jun 2021
-14.08M
Maximum
Jun 2019
-25.10M
Average
-23.50M
Median
Free Cash Flow (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 16.18M |
Ardelyx Inc | -35.87M |
Arcus Biosciences Inc | -6.00M |
Arcutis Biotherapeutics Inc | -31.60M |
SeaStar Medical Holding Corp | -4.485M |